Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan 1;5(1):166-72.
doi: 10.1177/193229681100500123.

Noninvasive diagnostic devices for diabetes through measuring tear glucose

Affiliations
Review

Noninvasive diagnostic devices for diabetes through measuring tear glucose

Jin Zhang et al. J Diabetes Sci Technol. .

Abstract

This article reviews the development of a noninvasive diagnostic for diabetes by detecting ocular glucose. Early diagnosis and daily management are very important to diabetes patients to ensure a healthy life. Commercial blood glucose sensors have been used since the 1970s. Millions of diabetes patients have to prick their finger for a drop of blood 4-5 times a day to check blood glucose levels--almost 1800 times annually. There is a strong need to have a noninvasive device to help patients to manage the disease easily and painlessly. Instead of detecting the glucose in blood, monitoring the glucose level in other body fluids may provide a feasible approach for noninvasive diagnosis and diabetes control. Tear glucose has been studied for several decades. This article reviews studies on ocular glucose and its monitoring methods. Attempts to continuously monitor the concentration of tear glucose by using contact lens-based sensors are discussed as well as our current development of a nanostructured lens-based sensor for diabetes. This disposable biosensor for the detection of tear glucose may provide an alternative method to help patients manage the disease conveniently.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An example of the FRET pair-labeled Con A.
Figure 2
Figure 2
Photobleaching behavior of FITC: free FITC (black) and foam-structured FMSNs (red).
Figure 3
Figure 3
Transmission electron microscopy micrograph of FMSNs.
Figure 4
Figure 4
Lens sensor developed in Zhang’s lab at the University of Western Ontario, London, Ontario.
Figure 5
Figure 5
LCSM image: before (right) and after (left) adding 10 µl aqueous glucose (1 mg/dl).
Figure 6
Figure 6
Fluorescence responses as the function of the concentration of glucose, which can be continuously monitored for 5 days.

References

    1. World Health Organization. Diabetes: Fact sheet N°312. Geneva (Switzerland): WHO; 2009. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs312/en/">http://www.who.int/mediacentre/factsheets/fs312/en/</ext-link>. Accessed on December 23,2010.
    1. Canadian Diabetes Association. Diabetes Progress Report 2005. Toronto (Ontario): Canadian Diabetes Association; 2005. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.diabetes.ca/files/diabetesreport2005/CDA-diabetesreport-2005-...">http://www.diabetes.ca/files/diabetesreport2005/CDA-diabetesreport-2005-...</ext-link>.
    1. Shen YC, Davies AG, Linfield EH, Elsey TS, Taday PF, Arnone DD. The use of Fourier-transform infrared spectroscopy for the quantitative determination of glucose concentration in whole blood. Phys Med Biol. 2003;48(13):2023–2032. - PubMed
    1. Burmeister JJ, Arnold MA, Small GW. Noninvasive blood glucose measurements by near-infrared transmission spectroscopy across human tongues. Diabetes Technol Ther. 2000;2(1):5–16. - PubMed
    1. Nelson LA, McCann JC, Loepke AW, Wu J, Ben Dor B, Kurth CD. Development and validation of a multiwavelength spatial domain near-infrared oximeter to detect cerebral hypoxia-ischemia. J Biomed Opt. 2006;11(6):064022. - PubMed

MeSH terms